Vigil Neuroscience to Present at 2022 Jefferies Global Healthcare Conference
Jun 01, 2022
|
Vigil Neuroscience Reports First Quarter 2022 Financial Results and Provides Business Highlights
May 12, 2022
|
Vigil Neuroscience Expands Leadership Team and Board of Directors
Apr 20, 2022
|
Vigil Neuroscience Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights
Mar 25, 2022
|
Vigil Neuroscience to Present Key Considerations for Lead Indication ALSP at the 2022 American Academy of Neurology Annual Meeting
Mar 03, 2022
|
Vigil Neuroscience Announces Closing of Initial Public Offering
Jan 11, 2022
|
Vigil Neuroscience Announces Pricing of Initial Public Offering
Jan 06, 2022
|
Print Page
Email Alerts
RSS Feeds
Contact IR

Exit

You are leaving Vigil Neuroscience, Inc.’s website. You may return to Vigil Neuroscience, Inc.’s website by using the “Back” button on your Web browser toolbar or closing the window to the third-party website that you have opened. Do you wish to continue?